
Catalym
Operator of a biopharmaceutical company intended to transform cancer patients' lives by engaging their own immune systems. The company engages in developing antibodies that transform the tumor micro-e...
Valuation
$0
Share Price
N/A
Total Raised
$271.1M
Last Round
N/A